Workflow
NexPoint Real Estate Finance(NREF)
icon
Search documents
NexPoint Real Estate Finance(NREF) - 2025 Q1 - Earnings Call Transcript
2025-05-01 15:00
NexPoint Real Estate Finance (NREF) Q1 2025 Earnings Call May 01, 2025 11:00 AM ET Speaker0 As a reminder, today's call is being recorded. I will now hand today's call over to Kristin Griffith, Investor Relations. Please go ahead. Speaker1 Thank you. Good day, everyone, and welcome to NexLint Real Estate Finance conference call to review the company's results for the first quarter ended 03/31/2025. On the call today are Paul Richards, executive vice president and chief financial officer, and Matt McGriner, ...
NexPoint (NREF) Misses Q1 Earnings Estimates
ZACKS· 2025-05-01 14:35
NexPoint (NREF) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10.87%. A quarter ago, it was expected that this company would post earnings of $0.78 per share when it actually produced earnings of $0.83, delivering a surprise of 6.41%.Over the last four quarters, the company has surpass ...
NexPoint Real Estate Finance(NREF) - 2025 Q1 - Earnings Call Presentation
2025-05-01 14:22
NYSE:NREF 1Q 2022 FINANCIAL SUPPLEMENT 1Q 2025 Financial Supplement May 1, 2025 CONTACT NEXPOINT REAL ESTATE FINANCE (NYSE:NREF) 300 Crescent Court, Suite 700 Dallas, Texas 75201 (w) nref.nexpoint.com INVESTOR RELATIONS Kristen Griffith (e) kgriffith@nexpoint.com 28 APRIL 2022 NYSE:NR EF Cautionary Statements FORWARD LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current expe ...
NexPoint Real Estate Finance(NREF) - 2025 Q1 - Quarterly Results
2025-05-01 12:15
NREF Announces First Quarter 2025 Results, Provides Second Quarter 2025 Guidance Dallas, TX, Thursday, May 01, 2025 – NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended March 31, 2025. NREF reported net income attributable to common stockholders of $16.5 million, or $0.70 per diluted share1, for the three months ended March 31, 2025. EXHIBIT 99.1 Contact: Kristen Griffith Investor Relations IR@nexpoint.com Media: pro-nexpoint@ ...
NREF Announces First Quarter 2025 Results, Provides Second Quarter 2025 Guidance
Prnewswire· 2025-05-01 12:15
DALLAS, May 1, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended March 31, 2025.NREF reported net income attributable to common stockholders of $16.5 million, or $0.70 per diluted share1, for the three months ended March 31, 2025.NREF reported cash available for distribution2 of $10.5 million, or $0.45 per diluted common share2, for the three months ended March 31, 2025."NREF is pleased to announce anothe ...
NexPoint Real Estate Finance, Inc. Announces First Quarter 2025 Earnings Conference Call
Prnewswire· 2025-04-03 13:00
DALLAS, April 3, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") announced today that the Company is scheduled to host a conference call on Thursday, May 1, 2025, at 11:00 a.m. ET (10:00 a.m. CT), to discuss first quarter 2025 financial results.  The conference call can be accessed live over the phone by dialing 888-660-4430 or, for international callers, +1 646-960-0537 and using passcode Conference ID: 6891136.  A live audio webcast of the call will be available online ...
NexPoint Real Estate Finance(NREF) - 2024 Q4 - Annual Report
2025-03-27 11:09
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 10-K __________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39210 __________________________________ NexP ...
NexPoint Real Estate Finance: Making Hay While The Sun Shines
Seeking Alpha· 2025-03-21 09:14
I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...
NexPoint Real Estate Finance, Inc. Announces Record Date and Date of 2025 Annual Meeting of Stockholders
Prnewswire· 2025-03-14 22:00
DALLAS, March 14, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) ("NREF") announced today that the record date for determining stockholders entitled to vote at the 2025 Annual Meeting of Stockholders (the "Annual Meeting") will be Monday, March 24, 2025. The Annual Meeting will be held on Tuesday, May 20, 2025, beginning at 10:30 a.m. Central Time. The Annual Meeting will be held exclusively through a virtual format. Stockholders will not be able to attend the Annual Meeting in person, ...
NexPoint Real Estate Finance(NREF) - 2024 Q4 - Earnings Call Transcript
2025-02-27 22:43
Financial Data and Key Metrics Changes - For Q4 2024, the company reported net income of $0.43 per diluted share, down from $0.73 per diluted share in Q4 2023, attributed to unrealized losses on common stock investments and changes in net assets on CMBS VIEs [10] - Interest income decreased by $15.4 million to $32.3 million in Q4 2024 from $47.7 million in Q4 2023 [10] - Earnings available for distribution were $0.83 per diluted common share in Q4, compared to $0.44 per diluted common share in the same period of 2023 [11] - Cash available for distribution was $0.47 per diluted common share in Q4, down from $0.51 per diluted common share in Q4 2023 [12] - For the full year 2024, net income was $1.02 per diluted share, up from $0.60 per diluted share in 2023 [14] Business Line Data and Key Metrics Changes - The portfolio consists of 83 investments with an outstanding balance of $1.1 billion, allocated across various sectors including 15.5% single-family rental, 49.7% multifamily, and 31% life sciences [16] - The collateral on the portfolio is 76.5% stabilized with a loan-to-value ratio of 59.2% and a weighted average DSCR of 1.32 times [18] Market Data and Key Metrics Changes - Multifamily fundamentals are improving, with Q4 starts at 37,000 units, the lowest since Q4 2011, indicating a potential inflection point as supply wanes [21] - The company is actively underwriting $300 million of opportunities in life sciences, particularly in infrastructure and pharmaceutical manufacturing [24] Company Strategy and Development Direction - The company is optimistic about growth in 2025, particularly in the multifamily sector and life sciences, with plans to capitalize on construction financing and high-quality mezzanine opportunities [20][25] - The company is exploring multiple avenues for funding growth, including A-note warehouses and bond-rated deals [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the underlying credit profile of the portfolio and expects new lease growth to turn positive in the second half of the year [20] - The company is seeing increased activity in life sciences and advanced manufacturing, driven by reshoring trends [24] Other Important Information - The company paid a regular dividend of $0.50 per share in Q4 and has declared the same for Q1 2025 [12] - The debt-to-equity ratio stands at 1.39 times, with $799.3 million of debt outstanding [18] Q&A Session Summary Question: Can you talk about the returns on new investments and how they compare to other things in your pipeline? - Management indicated that Freddie K deals are expected to yield in the 8% to 9% range, with low to mid-teens type of return when leveraging [32] Question: Can you provide an update on life science investments and performance? - Management highlighted a $220 million commitment in Massachusetts, with a loan-to-cost attachment point of roughly 25% and a stabilized debt yield of over 30% [35] Question: Any updates on loan performance, particularly delinquent or defaulted loans? - Management noted a few watch list loans but emphasized overall strong portfolio performance with minimal delinquency [40] Question: Is the Cambridge deal purely speculative? - Management confirmed it is a speculative development but mentioned ongoing preleasing activity with significant interest [49][46]